Work package 4 – Improved availability of antibiotics through new economic models and measures against shortages.

Purpose: To increase the availability of antibiotics in Sweden through analyses of costs related to shortages, mapping of delivery chains and support to implementations of measures against shortages.

With experts from University of Gothenburg, University of Linköping, Uppsala University, RISE, the Public Health Agency of Sweden (PHAS), The Swedish Pharmacists Society, , the Research-based Pharmaceutical Industry association of Sweden, and the corporations MSD, Pfizer, Recipharm, Tamro and Viatris, work package 4 supports the measures that prevent and handle shortage situations of antibiotics. To motivate the investments needed for these measures, work package 4 will also perform health economic analyses of shortage situations, and also define new principles to evaluate the value of antibiotics, considering various dimensions of value. The effects of selected measures (e.g., safety stocks, central coordination, and fixed yearly payments) will be evaluated through modelling and simulations of the system for supply and purchase of antibiotics. Work package 4 also includes international cooperation and analyses of selected measures such as joint purchase and production of antibiotics.

Last modified: 2022-11-04